Total Funding
75
20
Total FundingSeries A raised
Growth Score
-7 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
881350
Orega Biotech is a biotech company committed to the development of immunotherapeutics for the treatment of cancer.
Gilles Alberici: Founder and CEO- Armand Bensussan: Founder and Scientific Advisor
About the Company
Orega Biotech is a biotech company committed to the development of immunotherapeutics for the treatment of cancer. Backed by INSERM-Transfert and OCTALFA, Orega Biotech was set up in March 2010 at the initiative of its four founders bringing together scientific and business skills. The company specializes in the development of monoclonal antibodies
for cancer immunotherapy. Focusing on tumor microenvironment, the company's target discovery program aims at discovering and validating novel clinically-relevant cancer targets.
Orega Biotech is headquartered in Écully, France.
